SIAMH is a healthcare service provider using advanced technology for early and accurate diagnosis and offering appropriate treatments for a wide spectrum of diseases and health conditions including cancer and neurodegenerative and cardiovascular diseases.
Singapore Institute of Advanced Medicine Holdings (SIAMH) has announced that it has lodged its preliminary offer document in connection with its proposed initial public offering (IPO) and listing on the Catalist of the Singapore Exchange (SGX:S68
) Securities Trading Limited (SGX-ST) on Nov 23.
Bursa-listed property developer Berjaya Corporation is the majority owner of SIAMH, its subsidiary.
